NIMSAH Trademark

Trademark Overview


On Friday, February 4, 2022, a trademark application was filed for NIMSAH with the United States Patent and Trademark Office. The USPTO has given the NIMSAH trademark a serial number of 97253497. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, January 2, 2024. This trademark is owned by Acasti Pharma US Inc.. The NIMSAH trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for treating subarachnoid hemorrhage administered by intravenous infusion and dispensed only in advanced medical care settings
nimsah

General Information


Serial Number97253497
Word MarkNIMSAH
Filing DateFriday, February 4, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, January 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements


Goods and Servicespharmaceutical preparations for treating subarachnoid hemorrhage administered by intravenous infusion and dispensed only in advanced medical care settings
Translation of Words in MarkThe wording "NIMSAH" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAcasti Pharma US Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902

Party NameAcasti Pharma US Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902

Trademark Events


Event DateEvent Description
Thursday, January 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 2, 2024SOU EXTENSION 1 GRANTED
Tuesday, January 2, 2024SOU EXTENSION 1 FILED
Tuesday, January 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 1, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 22, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, May 4, 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, May 1, 2023ASSIGNED TO PETITION STAFF
Tuesday, April 11, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, January 2, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 7, 2022EXAMINER'S AMENDMENT ENTERED
Monday, November 7, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 7, 2022EXAMINERS AMENDMENT E-MAILED
Monday, November 7, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, November 4, 2022ASSIGNED TO EXAMINER
Wednesday, February 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 8, 2022NEW APPLICATION ENTERED